J.W.G. van Putten

652 total citations
11 papers, 402 citations indexed

About

J.W.G. van Putten is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, J.W.G. van Putten has authored 11 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 2 papers in Surgery. Recurrent topics in J.W.G. van Putten's work include Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Diagnosis and Treatment (4 papers) and Lung Cancer Research Studies (4 papers). J.W.G. van Putten is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Diagnosis and Treatment (4 papers) and Lung Cancer Research Studies (4 papers). J.W.G. van Putten collaborates with scholars based in Netherlands, Germany and Switzerland. J.W.G. van Putten's co-authors include Harry J.M. Groen, Egbert F. Smit, Franz M.N.H. Schramel, Henk Kramer, Z. Erjavec, Elisabeth G.E. de Vries, Elisabeth A. Kastelijn, Pieter E. Postmus, N.J.J. Schlösser and Joris P. J. Slaets and has published in prestigious journals such as Scientific Reports, CHEST Journal and British Journal of Cancer.

In The Last Decade

J.W.G. van Putten

11 papers receiving 392 citations

Peers

J.W.G. van Putten

PRM

ONCOL

EPIDE

Sonam Puri United States

Fernando Barata Portugal

Melissa A.L. Vyfhuis United States

Akira Okita Japan

Laura R. Prakash United States

Sujay Srinivas India

Valeria Tonini Italy

Jacky Créquit France

Yves Rinaldi France

Johanna A.M.G. Tol Netherlands

Sonam Puri United States

J.W.G. van Putten

176 ×0.8

PRM

324 ×1.4

ONCOL

70 ×0.9

EPIDE

149 ×2.2

24 ×0.5

Citations per year, relative to J.W.G. van Putten J.W.G. van Putten (= 1×) peers Sonam Puri

Countries citing papers authored by J.W.G. van Putten

Since Specialization

Citations

This map shows the geographic impact of J.W.G. van Putten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.W.G. van Putten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.W.G. van Putten more than expected).

Fields of papers citing papers by J.W.G. van Putten

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.W.G. van Putten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.W.G. van Putten. The network helps show where J.W.G. van Putten may publish in the future.

Co-authorship network of co-authors of J.W.G. van Putten

This figure shows the co-authorship network connecting the top 25 collaborators of J.W.G. van Putten. A scholar is included among the top collaborators of J.W.G. van Putten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.W.G. van Putten. J.W.G. van Putten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Brusse‐Keizer, Marjolein, Hugo Schouwink, Frans H. de Jongh, et al.. (2022). Diagnosing Non-Small Cell Lung Cancer by Exhaled Breath Profiling Using an Electronic Nose. CHEST Journal. 163(3). 697–706. 44 indexed citations

Peters, Bas, Franz M.N.H. Schramel, Olaf H. Klungel, et al.. (2021). Real-world outcomes versus clinical trial results of immunotherapy in stage IV non-small cell lung cancer (NSCLC) in the Netherlands. Scientific Reports. 11(1). 6306–6306. 67 indexed citations

Schramel, Franz M.N.H., Harry J.M. Groen, E.M.W. van de Garde, et al.. (2020). Real‐world treatment patterns and outcomes of patients with extensive disease small cell lung cancer. European Journal of Cancer Care. 29(5). e13250–e13250. 13 indexed citations

Biesma, Bonne, A.N.M. Wymenga, Andrew Vincent, et al.. (2011). Quality of life, geriatric assessment and survival in elderly patients with non-small-cell lung cancer treated with carboplatin–gemcitabine or carboplatin–paclitaxel: NVALT-3 a phase III study. Annals of Oncology. 22(7). 1520–1527. 79 indexed citations

Kramer, Henk, et al.. (2004). Endoscopic ultrasound-guided fine-needle aspiration in patients with mediastinal abnormalities and previous extrathoracic malignancy. European Journal of Cancer. 40(4). 559–562. 27 indexed citations

Groen, Harry J.M., Eelco Fokkema, Paul R. Timmer, et al.. (2004). Continuously infused carboplatin used as radiosensitizer in locally unresectable non-small-cell lung cancer: a multicenter phase III study. Annals of Oncology. 15(3). 427–432. 41 indexed citations

Wachters, Floris M, J.W.G. van Putten, Henk Kramer, et al.. (2003). First-line gemcitabine with cisplatin or epirubicin in advanced non-small-cell lung cancer: a phase III trial. British Journal of Cancer. 89(7). 1192–1199. 53 indexed citations

Smit, Egbert F., J.W.G. van Putten, Harry J.M. Groen, et al.. (2001). Single-agent gemcitabine in patients with resistant small-cell lung cancer. Annals of Oncology. 12(4). 557–561. 56 indexed citations

Putten, J.W.G. van, Floris M Wachters, & Harry J.M. Groen. (2001). Docetaxel and carboplatin combination as second-line treatment in metastatic non-small-cell lung cancer(NSCLC). European Journal of Cancer. 37. S51–S51. 2 indexed citations

10.

Putten, J.W.G. van, et al.. (2000). Second-line treatment with single-agent gemcitabine (GEM) in patients (PTS) with advanced non-small-cell lung cancer (NSCLC). Lung Cancer. 29(1). 59–59. 1 indexed citations

11.

Putten, J.W.G. van, et al.. (2000). Activity of high-dose epirubicin combined with gemcitabine in advanced non-small-cell lung cancer: a multicenter phase I and II study. British Journal of Cancer. 82(4). 806–811. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact